KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares Outstanding
Ratios

TherapeuticsMD (TXMD) Shares Issued (2016 - 2023)

TherapeuticsMD filings provide 12 years of Shares Issued readings, the most recent being $2.0 million for Q4 2023.

  • On a quarterly basis, Shares Issued fell 17.95% to $2.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$178.1 million, a 20.24% decrease, with the full-year FY2023 number at $3.2 million, up 28.4% from a year prior.
  • Shares Issued hit $2.0 million in Q4 2023 for TherapeuticsMD, up from -$1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $182.6 million in Q3 2021 to a low of -$182.6 million in Q4 2021.
  • Median Shares Issued over the past 5 years was $100107.0 (2019), compared with a mean of $6.3 million.
  • The widest YoY moves for Shares Issued: up 209481.94% in 2021, down 160312.77% in 2021.
  • TherapeuticsMD's Shares Issued stood at $76.9 million in 2019, then crashed by 99.86% to $106000.0 in 2020, then crashed by 172325.47% to -$182.6 million in 2021, then skyrocketed by 101.34% to $2.4 million in 2022, then dropped by 17.95% to $2.0 million in 2023.
  • The last three reported values for Shares Issued were $2.0 million (Q4 2023), -$1000.0 (Q3 2023), and $2.4 million (Q4 2022) per Business Quant data.